Severe Weight Loss and Emaciation Following Topiramate Administration

Journal Title: International Neuropsychiatric Disease Journal - Year 2017, Vol 10, Issue 1

Abstract

Topiramate is an antiepileptic drug, used also for prevention of an episodic migraine. Its effects include sodium-channel-blocking activity, enhancement of cerebral GABA concentrations and antagonism of AMPA/kainate receptors, which leads to a decreased glutamate-mediated excitation. It is documented to possess weight reducing properties. It attenuates appetite through mechanisms that remain to be elucidated. Severe weight loss is not reported in the literature. We investigated one patient with severe weight loss (40.2% loss) resulted in emaciation and found that the implicated drug was topiramate. This notion was confirmed when we discontinued the implicated drug (Topiramate) as the patient regained his weight again to the previously recorded levels. Conclusion: Severe weight loss up to emaciation may occur after topiramate administration, Topiramate can be used to counteract the weight gain effect of antipsychotics, long acting topiramate preparation alone or in combination with long acting phentermine can be used to treat morbid obesity.

Authors and Affiliations

Mohammad Abu-Hegazy, Abdallah M. Almarzoogi, Sultan M. Almarzoogi, Waseem Marei M. Marei

Keywords

Related Articles

Conversion Disorder in the Elderly Population: Case Report

Conversion disorder is a psychological disorder that appears as a loss in individual’s motor and/or sensory functions without any apparent organic reason. It was reported that it is usually observed in 15 – 35 years old...

Sylvian Fissure Lipoma Associated with Middle Cerebral Artery Aneurysm – Report of a Rare Case Highlighting Imaging Pitfalls

Aim: We describe a 60 year old lady who had a Sylvian fissure lipoma associated with an underlying middle cerebral artery saccular aneurysm which is a rare association and describe its imaging features. Presentation of...

Novel GLRB Gene Mutation in a Saudi Baby with Hyperekplexia

Aim: We aim to describe a case of hyperekplexia in a Saudi neonate due to Novel mutation in GLRB. Case Presentation: One month old Saudi neonate with hypertonicity, repetitive episodes of jitteriness and exaggerated star...

Case Report: Childhood Disintegrative Disorder in a 17 Year Old Male Nigerian Adolescent

This case report aims to increase the awareness and hence enhance early detection of Heller’s syndrome by health professionals. Childhood disintegrative disorder otherwise referred to as Heller’s Syndrome or disintegrati...

Investigating the Frequency and Association of BACE1-AS rs147542312C/T with Alzheimer's Disease in Northwest of Iran

Background and Aims: Alzheimer’s disease is the most common neurodegenerative disorder worldwide. The long noncoding RNA, BACE1-AS, acts as a regulator of BACE1 transcript which its product involves in Alzheimer’s diseas...

Download PDF file
  • EP ID EP308488
  • DOI 10.9734/INDJ/2017/35961
  • Views 105
  • Downloads 0

How To Cite

Mohammad Abu-Hegazy, Abdallah M. Almarzoogi, Sultan M. Almarzoogi, Waseem Marei M. Marei (2017). Severe Weight Loss and Emaciation Following Topiramate Administration. International Neuropsychiatric Disease Journal, 10(1), 1-4. https://europub.co.uk/articles/-A-308488